Send to a friend

Dave Grable is a seasoned trial lawyer who represents companies and individuals in civil and criminal matters around the country.  He focuses on making complicated factual and legal issues simple and understandable for juries, judges, and other decision makers.

On the civil side, Mr. Grable has litigated disputes in a broad range of areas, including corporate fraud, breach of fiduciary duties, product liability, securities, trade secret theft, contract law, and insurance bad faith.

On the criminal/regulatory side, Mr. Grable has represented companies and individuals in investigations related to complex accounting, securities, health care, antitrust, tax, and other regulatory issues.   Mr. Grable has also represented individuals charged with federal and state crimes in pretrial, trial, and post-trial settings.

Before joining Quinn Emanuel, Mr. Grable served as a federal prosecutor in the Northern District of New York, where he tried several cases to guilty verdicts, and successfully briefed and argued several cases in the United States Court of Appeals for the Second Circuit, including two argued the same day -- United States v. Singh, 390 F.3d 168 (2d Cir. 2004) (affirming health care fraud convictions after trial) and United States v. Frampton, 382 F.3d 213 (2d Cir. 2004) (affirming attempted murder in aid of racketeering conviction after trial).  Mr. Grable also worked on anti-terrorism matters, and investigated and prosecuted the first ever material support of terrorism case brought in the Northern District of New York.

Lead trial counsel for aerospace company seeking tens of millions of dollars in damages against international conglomerate in connection with failed acquisition and theft of trade secrets.

Co-lead trial counsel in 59-count RICO case brought against highly successful businessman by Los Angeles U.S. Attorney’s Office.  Obtained dismissal of some RICO charges pre-trial, some during four-week trial, and remainder through post-trial motions based on government misconduct.

Trial counsel for Fortune 500 pharmaceutical company in multiple product liability cases.

Representing litigation trust against PricewaterhouseCoopers in connection with implosion of SemGroup, L.P., the 18th largest private company in the country before it filed for chapter 11 in 2008.  Claims seek over $2 billion in damages.

Representing multiple institutional investors in investigation and litigation of claims arising out of investments in collateralized debt obligations, residential mortgage backed securities, and related derivatives.

Represented leading mutual fund in $40 million action against Citibank brought under Pennsylvania Securities Act relating to Enron credit-linked notes.

Represented chief executive of Fortune 500 company in Department of Justice price-fixing investigation.

Represented subsidiary of Fortune 100 company in Department of Justice, SEC, and state regulator investigation into finite reinsurance arrangements.

Represented Fortune 100 company, executive of Fortune 500 company, and executives of publicly-traded technology companies in separate U.S. Attorney investigations into stock option grants.

Represented executive of Fortune 500 company in SEC insider trading investigation.

Represented individuals in federal grand jury investigations pending in Los Angeles, Orange County, the Eastern District of Virginia, Washington, D.C., and the Southern District of New York.